Resultaträkning AbbVie Inc.

Aktier

ABBV

US00287Y1091

Farmaceutiska produkter

Marknaden stängd - Nyse Andra börsplatser 22:00:02 09.07.2025			5-dagars förändring	Förändring 1 jan.
190,62 ^USD	+0,45 %		−0,07 %	+7,27 %

09.07.	Stora affärer med amerikanska läkemedels- och bioteknikbolag under det senaste decenniet	RE
09.07.	Hälsoronden: Experimentellt Bayer-läkemedel lindrar klimakterieliknande besvär vid bröstcancerbehandling	RE

cd09867f8ef15e.rQMJNE_p5gJc0v6VyVK5xTkSIBtXdld83h7tv0RW1z4.3Fw5Wj-vhF1tmKvtjw3MlVRHalZnJQYLnWeniSUygln1SyRlJ72sVhrhiQ

Publicerade finansiella data: ABBVIE INC.

Årlig

Kvartalsvis

Halvårsvis

YTD

LTM

Skatteperiod: December	2020	2021	2022	2023	2024
Revenues	45,8 md	56,2 md	58,05 md	54,32 md	56,33 md
Total Revenues	45,8 md	56,2 md	58,05 md	54,32 md	56,33 md
Cost of Goods Sold, Total	14,06 md	17,31 md	16,53 md	16,73 md	16,69 md
Gross Profit	31,75 md	38,88 md	41,53 md	37,59 md	39,64 md
Selling General & Admin Expenses, Total	9,87 md	11,87 md	12,08 md	12,9 md	13,19 md
R&D Expenses	6,18 md	6,98 md	6,49 md	7,04 md	8,13 md
Other Operating Expenses	-	500 mn	−1 mn	−10 mn	−7 mn
Other Operating Expenses, Total	16,05 md	19,35 md	18,57 md	19,93 md	21,31 md
Operating Income	15,7 md	19,53 md	22,96 md	17,66 md	18,33 md
Interest Expense, Total	−2,45 md	−2,42 md	−2,23 md	−2,22 md	−2,81 md
Interest And Investment Income	174 mn	39 mn	186 mn	540 mn	648 mn
Net Interest Expenses	−2,28 md	−2,38 md	−2,04 md	−1,68 md	−2,16 md
Currency Exchange Gains (Loss)	−71 mn	−51 mn	−148 mn	−146 mn	−21 mn
Other Non Operating Income (Expenses)	113 mn	55 mn	142 mn	190 mn	271 mn
EBT, Excl. Unusual Items	13,46 md	17,15 md	20,91 md	16,02 md	16,42 md
Restructuring Charges	-	-	-	-	-
Merger & Related Restructuring Charges	−3,11 md	−587 mn	−768 mn	−119 mn	−792 mn
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-	68 mn	172 mn	-	-
Asset Writedown	-	-	−876 mn	−4,23 md	−4,48 md
In Process R&D Expenses	−1,2 md	−962 mn	−697 mn	−778 mn	−2,76 md
Legal Settlements	-	-	−2,5 md	485 mn	−910 mn
Other Unusual Items	−5,75 md	−2,68 md	−2,76 md	−5,13 md	−3,77 md
EBT, Incl. Unusual Items	3,4 md	12,99 md	13,48 md	6,25 md	3,72 md
Income Tax Expense	−1,22 md	1,44 md	1,63 md	1,38 md	−570 mn
Earnings From Continuing Operations	4,62 md	11,55 md	11,84 md	4,87 md	4,29 md
Net Income to Company	4,62 md	11,55 md	11,84 md	4,87 md	4,29 md
Minority Interest	−6 mn	−7 mn	−9 mn	−10 mn	−8 mn
Net Income - (IS)	4,62 md	11,54 md	11,84 md	4,86 md	4,28 md
Preferred Dividend and Other Adjustments	60 mn	74 mn	54 mn	43 mn	40 mn
Net Income to Common Incl Extra Items	4,56 md	11,47 md	11,78 md	4,82 md	4,24 md
Net Income to Common Excl. Extra Items	4,56 md	11,47 md	11,78 md	4,82 md	4,24 md
Per aktie poster
Net EPS - Basic	2,73	6,48	6,65	2,73	2,4
Basic EPS - Continuing Operations	2,73	6,48	6,65	2,73	2,4
Basic Weighted Average Shares Outstanding	1,67 md	1,77 md	1,77 md	1,77 md	1,77 md
Net EPS - Diluted	2,72	6,45	6,63	2,72	2,39
Diluted EPS - Continuing Operations	2,72	6,45	6,63	2,72	2,39
Diluted Weighted Average Shares Outstanding	1,67 md	1,78 md	1,78 md	1,77 md	1,77 md
Normalized Basic EPS	5,04	6,05	7,37	5,66	5,8
Normalized Diluted EPS	5,03	6,03	7,34	5,64	5,78
Dividend Per Share	4,84	5,31	5,71	5,99	6,29
Payout Ratio	167,16	80,24	84,85	216,72	257,71
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Kompletterande punkter
EBITDA	22,17 md	28,05 md	31,42 md	26,36 md	26,72 md
EBITA	21,5 md	27,25 md	30,65 md	25,61 md	25,95 md
EBIT	15,7 md	19,53 md	22,96 md	17,66 md	18,33 md
EBITDAR	22,48 md	28,4 md	31,76 md	26,66 md	27,06 md
Effective Tax Rate - (Ratio)	−36,02	11,09	12,11	22,03	−15,34
Current Domestic Taxes	907 mn	1,99 md	2,65 md	3,27 md	−331 mn
Current Foreign Taxes	194 mn	351 mn	916 mn	994 mn	1,21 md
Total Current Taxes	1,1 md	2,34 md	3,56 md	4,27 md	879 mn
Deferred Domestic Taxes	−58 mn	−839 mn	−1,51 md	−2,32 md	−1,3 md
Deferred Foreign Taxes	−2,27 md	−59 mn	−419 mn	−565 mn	−146 mn
Total Deferred Taxes	−2,32 md	−898 mn	−1,93 md	−2,89 md	−1,45 md
Normalized Net Income	8,41 md	10,71 md	13,06 md	10 md	10,26 md
Interest Capitalized	-	-	-	-	-
Interest on Long-Term Debt	-	-	-	-	2,81 md
Non-Cash Pension Expense	−82 mn	−136 mn	−182 mn	−274 mn	−282 mn
Kompletterande driftskostnadsposter
Advertising Expense	1,8 md	2,1 md	2 md	2,2 md	2,1 md
Selling and Marketing Expenses	1,8 md	2,1 md	2 md	2,2 md	2,1 md
Research And Development Expense From Footnotes	7,76 md	8,05 md	7,21 md	8,45 md	15,55 md
Net Rental Expense, Total	311 mn	353 mn	339 mn	305 mn	347 mn
Imputed Operating Lease Interest Expense	79,16 mn	83,09 mn	85,07 mn	86,71 mn	122 mn
Imputed Operating Lease Depreciation	232 mn	270 mn	254 mn	218 mn	225 mn
Stock-Based Comp., COGS (Total)	47 mn	46 mn	38 mn	46 mn	91 mn
Stock-Based Comp., R&D Exp. (Total)	247 mn	226 mn	232 mn	278 mn	525 mn
Stock-Based Comp., SG&A Exp. (Total)	459 mn	420 mn	401 mn	423 mn	805 mn
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	753 mn	692 mn	671 mn	747 mn	1,42 md

Skatteperiod: December	2020	2021	2022	2023	2024
TILLGÅNGAR
Cash And Equivalents	8,45 md	9,75 md	9,2 md	12,81 md	5,52 md
Short Term Investments	30 mn	84 mn	28 mn	2 mn	31 mn
Trading Asset Securities, Total	7 mn	-	-	-	-
Total Cash And Short Term Investments	8,49 md	9,83 md	9,23 md	12,82 md	5,56 md
Accounts Receivable, Total	8,82 md	9,98 md	11,25 md	11,16 md	10,92 md
Other Receivables	-	-	-	-	-
Total Receivables	8,82 md	9,98 md	11,25 md	11,16 md	10,92 md
Inventory	3,31 md	3,13 md	3,58 md	4,1 md	4,18 md
Prepaid Expenses	3,5 md	4,77 md	4,31 md	4,87 md	4,76 md
Other Current Assets, Total	51 mn	226 mn	88 mn	66 mn	165 mn
Total Current Assets	24,17 md	27,93 md	28,46 md	33 md	25,58 md
Gross Property Plant And Equipment	11,75 md	11,49 md	11,72 md	12,38 md	12,99 md
Accumulated Depreciation	−5,61 md	−5,62 md	−6,05 md	−6,65 md	−7,13 md
Net Property Plant And Equipment	6,14 md	5,87 md	5,67 md	5,73 md	5,86 md
Long-term Investments	424 mn	318 mn	241 mn	304 mn	279 mn
Goodwill	33,12 md	32,38 md	32,16 md	32,29 md	34,96 md
Other Intangibles, Total	82,88 md	75,95 md	67,44 md	55,61 md	60,07 md
Other Long-Term Assets, Total	3,82 md	4,08 md	4,83 md	7,77 md	8,42 md
Total Assets	151 md	147 md	139 md	135 md	135 md
Skulder
Accounts Payable, Total	2,28 md	2,88 md	2,93 md	3,69 md	2,94 md
Accrued Expenses, Total	9,34 md	10,7 md	12,5 md	15,79 md	16,82 md
Short-term Borrowings	34 mn	14 mn	1 mn	-	-
Current Portion of Long-Term Debt	8,47 md	12,48 md	4,14 md	7,18 md	6,79 md
Current Portion of Leases	183 mn	187 mn	183 mn	181 mn	195 mn
Other Current Liabilities	8,35 md	8,93 md	9,78 md	11,01 md	12 md
Total Current Liabilities	28,66 md	35,19 md	29,54 md	37,84 md	38,75 md
Long-Term Debt	77,55 md	64,18 md	59,49 md	52,46 md	60,32 md
Long-Term Leases	853 mn	738 mn	771 mn	762 mn	720 mn
Pension & Other Post Retirement Benefits	3,41 md	3,15 md	1,64 md	1,54 md	1,23 md
Deferred Tax Liability Non Current	3,65 md	3,01 md	2,19 md	1,95 md	2,58 md
Other Non Current Liabilities	23,34 md	24,82 md	27,89 md	29,76 md	28,2 md
Total Liabilities	137 md	131 md	122 md	124 md	132 md
Common Stock, Total	18 mn	18 mn	18 mn	18 mn	18 mn
Additional Paid In Capital	17,38 md	18,3 md	19,24 md	20,18 md	21,33 md
Retained Earnings	1,06 md	3,13 md	4,78 md	−1 md	−7,9 md
Treasury Stock	−2,26 md	−3,14 md	−4,59 md	−6,53 md	−8,2 md
Comprehensive Income and Other	−3,12 md	−2,9 md	−2,2 md	−2,3 md	−1,92 md
Total Common Equity	13,08 md	15,41 md	17,25 md	10,36 md	3,32 md
Minority Interest	21 mn	28 mn	33 mn	37 mn	39 mn
Total Equity	13,1 md	15,44 md	17,29 md	10,4 md	3,36 md
Total Liabilities And Equity	151 md	147 md	139 md	135 md	135 md
Kompletterande objekt
ECS Total Shares Outstanding on Filing Date	1,77 md	1,77 md	1,77 md	1,77 md	1,77 md
ECS Total Common Shares Outstanding	1,77 md	1,77 md	1,77 md	1,77 md	1,77 md
Book Value / Share	7,41	8,71	9,75	5,87	1,88
Tangible Book Value	−103 md	−92,92 md	−82,34 md	−77,54 md	−91,7 md
Tangible Book Value Per Share	−58,31	−52,55	−46,54	−43,91	−51,95
Total Debt	87,1 md	77,6 md	64,58 md	60,58 md	68,02 md
Net Debt	78,61 md	67,77 md	55,35 md	47,76 md	62,46 md
Debt Equivalent of Unfunded Proj. Benefit Obligation	2,09 md	1,35 md	116 mn	−295 mn	−1,59 md
Debt Equivalent Oper. Leases	2,49 md	2,82 md	2,71 md	2,44 md	2,78 md
Minority Interest, Total (Incl. Fin. Div)	21 mn	28 mn	33 mn	37 mn	39 mn
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	791 mn	1 md	1 md	1,1 md	1,06 md
Inventories - Work In Process, Total	1,2 md	1,19 md	1,42 md	1,64 md	1,95 md
Inventories - Finished Goods, Total	1,32 md	932 mn	1,16 md	1,36 md	1,17 md
Land - (BS)	288 mn	287 mn	286 mn	286 mn	284 mn
Buildings, Total	2,56 md	2,79 md	2,74 md	2,83 md	2,9 md
Machinery, Total	6,98 md	6,85 md	7,11 md	7,45 md	8 md
Full Time Employees	47 tn	50 tn	50 tn	50 tn	55 tn
Accumulated Allowance for Doubtful Accounts (Supple)	262 mn	-	-	-	-

Skatteperiod: December	2020	2021	2022	2023	2024
Net Income	4,62 md	11,54 md	11,84 md	4,86 md	4,28 md
Depreciation & Amortization - CF	666 mn	803 mn	778 mn	752 mn	764 mn
Amortization of Goodwill and Intangible Assets - (CF)	5,8 md	7,72 md	7,69 md	7,95 md	7,62 md
Depreciation & Amortization, Total	6,47 md	8,52 md	8,47 md	8,7 md	8,39 md
(Gain) Loss From Sale Of Asset	-	−68 mn	−172 mn	-	-
Asset Writedown & Restructuring Costs	1,2 md	962 mn	1,47 md	5,01 md	7,23 md
Stock-Based Compensation (CF)	753 mn	692 mn	671 mn	747 mn	911 mn
Other Operating Activities, Total	4,44 md	2,45 md	2,93 md	711 mn	780 mn
Change In Accounts Receivable	−929 mn	−1,32 md	−1,46 md	66 mn	207 mn
Change In Inventories	−40 mn	−142 mn	−686 mn	−417 mn	−319 mn
Change In Accounts Payable	1,51 md	1,63 md	1,6 md	3,84 md	177 mn
Change In Deferred Taxes	−573 mn	−1,29 md	542 mn	−488 mn	−3,21 md
Change in Other Net Operating Assets	134 mn	−197 mn	−264 mn	−188 mn	361 mn
Cash from Operations	17,59 md	22,78 md	24,94 md	22,84 md	18,81 md
Capital Expenditure	−798 mn	−787 mn	−695 mn	−777 mn	−974 mn
Cash Acquisitions	−39,61 md	−1,9 md	−794 mn	−1,22 md	−20,52 md
Investment in Marketable and Equity Securities, Total	1,46 md	−21 mn	92 mn	−22 mn	482 mn
Other Investing Activities, Total	1,39 md	366 mn	774 mn	13 mn	189 mn
Cash from Investing	−37,56 md	−2,34 md	−623 mn	−2,01 md	−20,82 md
Short Term Debt Issued, Total	-	-	-	-	5,01 md
Long-Term Debt Issued, Total	3 md	1 md	2 md	-	16,96 md
Total Debt Issued	3 md	1 md	2 md	-	21,97 md
Short Term Debt Repaid, Total	-	-	-	-	−5,01 md
Long-Term Debt Repaid, Total	−5,68 md	−9,41 md	−14,43 md	−4,15 md	−9,61 md
Total Debt Repaid	−5,68 md	−9,41 md	−14,43 md	−4,15 md	−14,62 md
Issuance of Common Stock	209 mn	244 mn	262 mn	180 mn	214 mn
Repurchase of Common Stock	−978 mn	−934 mn	−1,49 md	−1,97 md	−1,71 md
Common Dividends Paid	−7,72 md	−9,26 md	−10,04 md	−10,54 md	−11,02 md
Common & Preferred Stock Dividends Paid	−7,72 md	−9,26 md	−10,04 md	−10,54 md	−11,02 md
Other Financing Activities, Total	−333 mn	−674 mn	−1,1 md	−742 mn	−42 mn
Cash from Financing	−11,5 md	−19,04 md	−24,8 md	−17,22 md	−5,21 md
Foreign Exchange Rate Adjustments	−5 mn	−97 mn	−62 mn	5 mn	−65 mn
Net Change in Cash	−31,48 md	1,3 md	−545 mn	3,61 md	−7,29 md
Kompletterande punkter
Cash Interest Paid	2,62 md	2,71 md	2,55 md	2,47 md	2,81 md
Cash Income Tax Paid (Refund)	1,67 md	3,65 md	2,99 md	4,7 md	4,06 md
Levered Free Cash Flow	16,86 md	19,25 md	22,97 md	22,63 md	19,98 md
Unlevered Free Cash Flow	18,39 md	20,76 md	24,36 md	24,02 md	21,73 md
Change In Net Working Capital	−2,16 md	−133 mn	−1,57 md	−4,31 md	−1,44 md
Net Debt Issued / Repaid	−2,68 md	−8,41 md	−12,43 md	−4,15 md	7,35 md

Skatteperiod: December	2020	2021	2022	2023	2024
Lönsamhet
Return on Assets	8,19	8,22	10,06	8,07	8,49
Return on Total Capital	12,33	12,63	16,41	14,44	16,13
Return On Equity %	187,7	80,95	72,4	35,2	62,29
Return on Common Equity	185,81	80,52	72,14	34,91	61,94
Marginalanalys
Gross Profit Margin %	69,31	69,19	71,53	69,21	70,37
SG&A Margin	21,54	21,13	20,82	23,76	23,41
EBITDA Margin %	48,4	49,91	54,13	48,53	47,43
EBITA Margin %	46,95	48,48	52,79	47,14	46,07
EBIT Margin %	34,27	34,75	39,54	32,51	32,54
Income From Continuing Operations Margin %	10,09	20,55	20,4	8,97	7,61
Net Income Margin %	10,08	20,54	20,39	8,95	7,59
Net Avail. For Common Margin %	9,95	20,41	20,29	8,87	7,52
Normalized Net Income Margin	18,35	19,06	22,49	18,41	18,21
Levered Free Cash Flow Margin	36,81	34,25	39,56	41,66	35,46
Unlevered Free Cash Flow Margin	40,16	36,95	41,96	44,22	38,58
Tillgångsomslutning
Asset Turnover	0,38	0,38	0,41	0,4	0,42
Fixed Assets Turnover	9,69	9,35	10,06	9,53	9,72
Receivables Turnover (Average Receivables)	6,43	5,98	5,47	4,85	5,1
Inventory Turnover (Average Inventory)	5,49	5,38	4,93	4,36	4,03
Kortfristig likviditet
Current Ratio	0,84	0,79	0,96	0,87	0,66
Quick Ratio	0,6	0,56	0,69	0,63	0,43
Operating Cash Flow to Current Liabilities	0,61	0,65	0,84	0,6	0,49
Days Sales Outstanding (Average Receivables)	56,93	61,05	66,74	75,29	71,71
Days Outstanding Inventory (Average Inventory)	66,69	67,86	74,06	83,78	90,79
Average Days Payable Outstanding	43,86	54,95	62,52	70,07	72,38
Cash Conversion Cycle (Average Days)	79,76	73,96	78,29	88,99	90,12
Långsiktig solvens
Total Debt/Equity	665,01	502,7	373,59	582,66	2,02 tn
Total Debt / Total Capital	86,93	83,41	78,88	85,35	95,29
LT Debt/Equity	598,66	420,56	348,61	511,9	1,81 tn
Long-Term Debt / Total Capital	78,25	69,78	73,61	74,99	85,51
Total Liabilities / Total Assets	91,3	89,47	87,55	92,28	97,51
EBIT / Interest Expense	6,4	8,06	10,29	7,94	6,53
EBITDA / Interest Expense	9,16	11,72	14,24	11,99	9,64
(EBITDA - Capex) / Interest Expense	8,84	11,4	13,93	11,64	9,29
Total Debt / EBITDA	3,87	2,73	2,03	2,27	2,51
Net Debt / EBITDA	3,5	2,39	1,74	1,79	2,31
Total Debt / (EBITDA - Capex)	4,02	2,81	2,08	2,34	2,61
Net Debt / (EBITDA - Capex)	3,63	2,45	1,78	1,85	2,39
Tillväxt jämfört med föregående år
Total Revenues, 1 Yr. Growth %	37,69	22,69	3,3	−6,44	3,71
Gross Profit, 1 Yr. Growth %	22,92	22,48	3,6	−9,48	5,46
EBITDA, 1 Yr. Growth %	41,08	26,52	6,84	−16,12	1,37
EBITA, 1 Yr. Growth %	41,01	26,71	7,12	−16,45	1,36
EBIT, 1 Yr. Growth %	14,62	24,4	9,89	−23,07	3,81
Earnings From Cont. Operations, 1 Yr. Growth %	−41,36	149,87	2,56	−58,86	−12,05
Net Income, 1 Yr. Growth %	−41,44	150,04	2,55	−58,91	−12,03
Normalized Net Income, 1 Yr. Growth %	10,67	27,41	12,93	−23,4	2,53
Diluted EPS Before Extra, 1 Yr. Growth %	−48,48	137,13	2,79	−58,97	−12,13
Accounts Receivable, 1 Yr. Growth %	62,53	13,09	12,8	−0,88	−2,12
Inventory, 1 Yr. Growth %	82,57	−5,5	14,42	14,53	2
Net Property, Plant and Equip., 1 Yr. Growth %	85,81	−4,41	−3,41	1,08	2,16
Total Assets, 1 Yr. Growth %	68,96	−2,68	−5,27	−2,95	0,33
Tangible Book Value, 1 Yr. Growth %	142,6	−9,72	−11,39	−5,83	18,26
Common Equity, 1 Yr. Growth %	−260,01	17,83	11,98	−39,96	−67,91
Cash From Operations, 1 Yr. Growth %	32	29,5	9,51	−8,44	−17,66
Capital Expenditures, 1 Yr. Growth %	44,57	−1,38	−11,69	11,8	25,35
Levered Free Cash Flow, 1 Yr. Growth %	100,26	14,17	14,25	−1,47	−11,72
Unlevered Free Cash Flow, 1 Yr. Growth %	92,93	12,88	12,7	−1,4	−9,52
Dividend Per Share, 1 Yr. Growth %	10,25	9,71	7,53	4,9	5,01
Sammansatt Årlig Tillväxthastighet Över Två År
Total Revenues, 2 Yr. CAGR %	18,26	29,97	12,58	−1,69	−1,49
Gross Profit, 2 Yr. CAGR %	12,61	22,7	16,6	−1,67	−2,29
EBITDA, 2 Yr. CAGR %	27,27	31,33	21,9	−3,46	−3,51
EBITA, 2 Yr. CAGR %	27,55	31,32	22,32	−3,46	−3,58
EBIT, 2 Yr. CAGR %	14,75	17,08	25,07	−5,46	−4,8
Earnings From Cont. Operations, 2 Yr. CAGR %	−9,85	21,05	60,09	−35,04	−39,85
Net Income, 2 Yr. CAGR %	−9,91	21,01	60,13	−35,09	−39,88
Normalized Net Income, 2 Yr. CAGR %	12,17	16,14	29,65	−4,01	−4,95
Diluted EPS Before Extra, 2 Yr. CAGR %	−13,79	10,53	56,12	−35,06	−39,96
Accounts Receivable, 2 Yr. CAGR %	28,01	35,58	12,95	5,74	−1,5
Inventory, 2 Yr. CAGR %	43,61	31,35	3,98	14,47	8,08
Net Property, Plant and Equip., 2 Yr. CAGR %	45,97	33,27	−3,91	−1,19	1,62
Total Assets, 2 Yr. CAGR %	59,27	28,23	−3,98	−4,12	−1,32
Tangible Book Value, 2 Yr. CAGR %	50,66	48	−10,56	−8,65	5,53
Common Equity, 2 Yr. CAGR %	24,43	37,31	14,87	−18	−56,1
Cash From Operations, 2 Yr. CAGR %	14,45	30,75	19,09	0,14	−13,17
Capital Expenditures, 2 Yr. CAGR %	11,84	19,4	−6,68	−0,64	18,38
Levered Free Cash Flow, 2 Yr. CAGR %	16,55	48,21	18,98	8,02	−3,06
Unlevered Free Cash Flow, 2 Yr. CAGR %	17,8	44,98	17,13	7,18	−2,06
Dividend Per Share, 2 Yr. CAGR %	10,69	9,98	8,62	6,21	4,96
Treårig Sammansatt Årlig Tillväxthastighet
Total Revenues, 3 Yr. CAGR %	17,53	19,72	20,4	5,85	0,08
Gross Profit, 3 Yr. CAGR %	13,82	15,81	17,15	7,16	0,65
EBITDA, 3 Yr. CAGR %	23,48	27,02	24,55	7,62	−1,88
EBITA, 3 Yr. CAGR %	23,74	27,27	24,71	7,73	−1,88
EBIT, 3 Yr. CAGR %	15,18	17,88	17,24	6,36	−2,47
Earnings From Cont. Operations, 3 Yr. CAGR %	−4,51	26,64	14,54	1,78	−28,14
Net Income, 3 Yr. CAGR %	−4,56	26,61	14,51	1,75	−28,17
Normalized Net Income, 3 Yr. CAGR %	14,57	17,03	18,03	8,79	−1,87
Diluted EPS Before Extra, 3 Yr. CAGR %	−6,24	20,79	7,88	0	−28,17
Accounts Receivable, 3 Yr. CAGR %	20,14	22,83	27,51	8,14	3,05
Inventory, 3 Yr. CAGR %	27,29	24,91	25,45	7,39	10,16
Net Property, Plant and Equip., 3 Yr. CAGR %	29,89	26,76	19,71	−2,28	−0,09
Total Assets, 3 Yr. CAGR %	28,61	35,15	15,92	−3,64	−2,66
Tangible Book Value, 3 Yr. CAGR %	39,09	27,02	24,74	−9,01	−0,44
Common Equity, 3 Yr. CAGR %	36,89	22,19	28,29	−7,47	−40,02
Cash From Operations, 3 Yr. CAGR %	20,87	19,26	23,25	9,1	−6,19
Capital Expenditures, 3 Yr. CAGR %	14,69	7,25	7,98	−0,88	7,36
Levered Free Cash Flow, 3 Yr. CAGR %	39,46	15,75	37,87	11,73	0,99
Unlevered Free Cash Flow, 3 Yr. CAGR %	38,43	16,14	35,1	10,59	1,3
Dividend Per Share, 3 Yr. CAGR %	22,55	10,37	9,16	7,36	5,81
Sammansatt Årlig Tillväxthastighet Över Fem År
Total Revenues, 5 Yr. CAGR %	14,91	16,99	15,52	10,65	11,11
Gross Profit, 5 Yr. CAGR %	11,26	14,4	14,04	8,47	8,95
EBITDA, 5 Yr. CAGR %	18	21,01	21,69	14	10,44
EBITA, 5 Yr. CAGR %	18,32	21,27	21,98	14,14	10,44
EBIT, 5 Yr. CAGR %	12,13	15,21	17,45	8,17	5,17
Earnings From Cont. Operations, 5 Yr. CAGR %	−2,12	14,17	17,41	−3,04	−11,47
Net Income, 5 Yr. CAGR %	−2,14	14,16	17,39	−3,08	−11,5
Normalized Net Income, 5 Yr. CAGR %	10,95	15,46	18,49	8,4	5,25
Diluted EPS Before Extra, 5 Yr. CAGR %	−2,77	12,18	14,97	−5,76	−14,66
Accounts Receivable, 5 Yr. CAGR %	13,28	15,96	17,21	15,68	15
Inventory, 5 Yr. CAGR %	14	16,72	17,4	20,63	18,19
Net Property, Plant and Equip., 5 Yr. CAGR %	19,09	17,66	15,14	14,74	12,12
Total Assets, 5 Yr. CAGR %	23,2	17,26	14,42	17,81	8,69
Tangible Book Value, 5 Yr. CAGR %	28,89	18,55	16,57	11,33	16,67
Common Equity, 5 Yr. CAGR %	27,08	27,15	27,62	4,17	−16,46
Cash From Operations, 5 Yr. CAGR %	18,48	26,47	20,15	11,21	7,14
Capital Expenditures, 5 Yr. CAGR %	8,45	10,44	5,61	4,02	12,03
Levered Free Cash Flow, 5 Yr. CAGR %	19,29	28,36	29,87	12,76	17,92
Unlevered Free Cash Flow, 5 Yr. CAGR %	19,88	27,43	28,57	12,62	17,08
Dividend Per Share, 5 Yr. CAGR %	18,17	17,71	16,77	8,68	7,46